Boston, MA -- (SBWIRE) -- 01/08/2014 -- At winstonsmallcap.com we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. Let have a Look on: Parkway Properties Inc(NYSE:PKY), Novavax, Inc.(NASDAQ:NVAX), Beazer Homes USA, Inc.(NYSE:BZH), Dendreon Corporation(NASDAQ:DNDN).
Parkway Properties Inc(NYSE:PKY) opened its shares at the price of $18.11 for the day. Its closing price was $18.16 after losing -4.22% for the day. The company traded with the total volume of 8.02 million shares, while its average trading volume remained 634,901 shares. The beta stands at 1.61. Parkway Properties, Inc. (Parkway) is a self-administered real estate investment trust (REIT) specializing in the ownership of office properties in higher growth submarkets in the Sunbelt region of the United States.
Has PKY Found The Bottom and Ready To Move Up? Find Out Here
Novavax, Inc.(NASDAQ:NVAX) percentage change plunged -3.93% to close at $5.01 with the total traded volume of 5.58 million shares, and average volume of 6.04 million. The 52 week range of the stock remained $1.68 - $5.45, while its day lowest price was $4.93 and it hit its day highest price at $5.29. Novavax, Inc., a clinical-stage biopharmaceutical company, focuses on developing recombinant protein nanoparticle vaccines to address a range of infectious diseases.
Has NVAX Found The Bottom And Ready To Gain Momentum? Find Out Here
Beazer Homes USA, Inc.(NYSE:BZH) started its trading session with the price of $23.93 and closed at $22.84 by losing -3.87%. Stocks traded with total volume of 1.06 million shares, while the average trading volume remained 671,423 shares. The beta stands at 5.07. Day range of the stock was $22.71 -$24.00. Beazer Homes USA, Inc. (Beazer) diversified homebuilder with active operations in 16 states. In the Company’s homebuilding operations, it designs, sells and builds single-family and multi-family homes.
Why Should Investors Buy BZH After the Recent Fall? Just Go Here and Find Out
Dendreon Corporation(NASDAQ:DNDN) ended its day with the loss of -3.86% and closed at the price of $2.87 after opening at $3.02. Stock traded during its last trading session with the total volume of 6.19 million shares, as compared to its average volume of 3.36 million shares. Dendreon Corporation, a biotechnology company, engages in the discovery, development, and commercialization of novel therapeutics to enhance cancer treatment options for patients. Its product portfolio includes active cellular immunotherapy and small molecule product candidates to treat a range of cancers.
Will DNDN Get Buyers Even After The Recent Rally? Find Out Here
Here at Winston we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. We focus on companies that we feel are trading at a discount to the market for various reasons. Enter your email and track our performance! We are sure you won’t be disappointed.
http://winstonsmallcap.com/ and its owners, and their affiliates, directors and officers, and immediate family members, are hereafter collectively referred to as “WSC” or “we” or “us” or “our”). WSC publishes information (the “Information”) about publicly traded companies (the “Profiled Company” or the “Profiled Companies”) which has been obtained from various sources including publicly available sources on the internet. WSC does not undertake any due diligence or investigation of the Information it obtains or publishes.
Read Full Disclaimer at: http://winstonsmallcap.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)